| 08/30/2016 |
Hydrogen Sulfide and Carbon Monoxide Protect Gastric Mucosa Compromised by Mild Stress Against Alendronate Injury
(Dig Dis Sci)
|
| 07/14/2016 |
Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses
(Osteoporos Int)
|
| 07/06/2016 |
Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study
(BMJ)
|
| 06/28/2016 |
Role of Side Effects, Physician Involvement, and Patient Perception in Non-Adherence with Oral Bisphosphonates
(Adv Ther)
|
| 06/15/2016 |
Aggravation of spinal cord compromise following new osteoporotic vertebral compression fracture prevented by teriparatide in patients with surgical contraindications
(Osteoporos Int)
|
| 05/24/2016 |
Male osteoporosis
(Z Rheumatol)
|
| 05/17/2016 |
Oral Bisphosphonates and Risk of Wet Age-Related Macular Degeneration
(Am J Ophthalmol)
|
| 04/06/2016 |
Calcinosis in juvenile dermatomyositis: frequency, risk factors and outcome
(Rheumatol Int)
|
| 03/31/2016 |
Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen
(Breast Cancer Res Treat)
|
| 03/24/2016 |
Treatment for osteoporosis in people with ß-thalassaemia
(Cochrane Database Syst Rev)
|
| 02/29/2016 |
Incidence of Atypical Femur Fractures in Cancer Patients: The MD Anderson Cancer Center Experience
(J Bone Miner Res)
|
| 02/19/2016 |
Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report
(BMC Musculoskel Disord)
|
| 01/25/2016 |
Urine Calcium and Bone Mineral Density in Calcium Stone-Forming Patients Treated with Alendronate and Hydrochlorothiazide
(Urol Int)
|
| 01/22/2016 |
Postmenopausal Osteoporosis
(N Engl J Med)
|
| 01/08/2016 |
Teriparatide Versus Alendronate for the Preservation of Bone Mineral Density After Total Hip Arthroplasty - A randomized Controlled Trial
(J Arthroplasty)
|
| 12/30/2015 |
Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study
(Osteoporos Int)
|
| 12/20/2015 |
Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday
(Osteoporos Int)
|
| 12/20/2015 |
Documentation of renal glomerular and tubular impairment and glomerular hyperfiltration in multitransfused patients with beta thalassemia
(Ann Hematol)
|
| 12/18/2015 |
An effect comparison of teriparatide and bisphosphonate on posterior lumbar interbody fusion in patients with osteoporosis: a prospective cohort study and preliminary data
(Eur Spine J)
|
| 12/17/2015 |
Efficacy and safety of pamidronate in children with vitamin D intoxication
(Pediatr Int)
|
| 12/10/2015 |
Bisphosphonate drug holidays - when, why and for how long?
(Climacteric)
|
| 11/26/2015 |
A comparison of the intrasubject variation of drug exposure between generic and brand-name drugs: a retrospective analysis of replicate design trials
(Br J Clin Pharmacol)
|
| 11/18/2015 |
Bilateral distal fibula fractures in a woman on long-term bisphosphonate therapy
(Osteoporos Int)
|
| 11/18/2015 |
A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates
(Osteoporos Int)
|
| 10/30/2015 |
FRAX and fracture prediction without bone mineral density
(Climacteric)
|
| 10/26/2015 |
Effects of switching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis: a 12-month prospective study
(Osteoporos Int)
|
| 10/20/2015 |
Treatment of osteoporosis after alendronate or risedronate
(Osteoporos Int)
|
| 09/09/2015 |
S3 guideline. Part 2: Non-Traumatic Avascular Femoral Head Necrosis in Adults - Untreated Course and Conservative Treatment
(Z Orthop Unfall)
|
| 08/14/2015 |
Recovery of Severe Muscular and Fascial Calcinosis After Treatment With Bisphosphonates in a Child With Juvenile Dermatomyositis
(JCR, Journal of Clinical Rheumatology)
|
| 08/06/2015 |
Vitamin D, osteoprotegerin/receptor activator of nuclear factor-kappaB ligand (OPG/RANKL) and inflammation with alendronate treatment in HIV-infected patients with reduced bone mineral density
(HIV Med)
|
